← Open Payments lookup

LINDA STEIMLING: Open Payments

NPI 1346358603 · PELLA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$996 in 43 payments from 12 companies in 2025. Trend: 2023 $309 · 2024 $621 · 2025 $996

Food & beverage: $996
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$359
ABBVIE INC.12$223
Teva Pharmaceuticals USA, Inc.4$92
E.R. Squibb & Sons, L.L.C.4$89
Vanda Pharmaceuticals Inc.2$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
Alkermes, Inc.1$31
Janssen Pharmaceuticals, Inc1$29
Neurocrine BioSciences, Inc.1$17
MDD US Operations, LLC1$16

Products named: REXULTI, VRAYLAR, COBENFY, AUSTEDO XR, FANAPT, CAPLYTA, ARISTADA, INVEGA SUSTENNA.

Industry payments across IA — which companies pay providers there.